Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Wyllie, D. Lachhwani, Ajay Gupta, A. Chirla, G. Cosmo, S. Worley, P. Kotagal, P. Ruggieri, W. Bingaman (2007)
Successful surgery for epilepsy due to early brain lesions despite generalized EEG findingsNeurology, 69
A. Vyas, Jaypalsing Ghunawat, A. Bagaria, D. Khandelwal (2021)
Uncommon Presentation of Rasmussen's EncephalitisNeurology India, 69
C. Bien, T. Granata, C. Antozzi, J. Cross, O. Dulac, M. Kurthen, H. Lassmann, R. Mantegazza, J. Villemure, R. Spreafico, C. Elger (2005)
Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement.Brain : a journal of neurology, 128 Pt 3
T Rasmussen (1958)
10.1212/WNL.8.6.435Neurology, 8
T. Ferrari, A. Hamad, L. Caboclo, R. Centeno, A. Zaninotto, M. Scattolin, Henrique Junior, C. Lancellotti, E. Yacubian (2011)
Atypical presentation in Rasmussen encephalitis: delayed late-onset periodic epileptic spasmsEpileptic Disorders, 13
CG Bien (2002)
10.1212/WNL.58.2.250Neurology, 58
K. Ramesha, B. Rajesh, R. Ashalatha, C. Kesavadas, M. Abraham, V. Radhakrishnan, P. Sarma, K. Radhakrishnan (2009)
Rasmussen's encephalitis: Experience from a developing country based on a group of medically and surgically treated patientsSeizure, 18
Acta Neurologica Belgica https://doi.org/10.1007/s13760-023-02267-1 LE T TER TO THE EDITOR Atypical Rasmussen’s encephalitis presenting as focal status epilepticus and periodic generalised myoclonus 1 2 3 Pavan Kumar Rudrabhatla · Fazala Mehnaz · Srinivas Metta Received: 20 September 2022 / Accepted: 5 April 2023 © The Author(s) under exclusive licence to Belgian Neurological Society 2023 Introduction twitching. He was given loading dose of intravenous (IV) phenytoin (PHT) elsewhere, but seizures persisted with no Rasmussen’s encephalitis (RE) is a rare chronic neuro- improvement in sensorium between the events. In the emer- logical disorder, first described by Theodore Rasmussen, gency room he was given loading dose (25 mg/kg) of IV a neurosurgeon, and his colleagues in the late 1950s [1]. sodium valproate (VPA), later was intubated, and started RE is characterised by inflammation of the cerebral cortex, on midazolam infusion (0.1 mg/kg IV bolus followed by drug-resistant epilepsy, and progressive neurological and 0.125 mg/kg/h infusion) in view of refractory seizures. cognitive deterioration. The 2005 European consensus on Upon shifting to the intensive care unit, he was noted to have pathogenesis, diagnosis, and treatment remains the accepted periodic generalised myoclonus and electroencephalogram guideline for RE [2]. We report an atypical presentation of (EEG) showed generalised slowing with variable interval RE
Acta Neurologica Belgica – Springer Journals
Published: Dec 1, 2023
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.